“We are currently testing Delta-optimized variants in clinical trials. They will form the basis for the booster vaccination for 2022. We are also trying out Delta plus Beta, the next mutation that scientists believe is likely.” PEGASUS REPORTERS, LAGOS | SEPTEMBER 23, 2021 ZURICH (Reuters) – Moderna Inc Chief Executive Stéphane Bancel thinks the coronavirus pandemic could be over ...
Read More »